This correspondence appreciates insights on managing genitourinary toxicity in prostate cancer, suggesting collaborative dialogue.
We thank the Italian Association of Radiotherapy and Clinical Oncology Education Committee for their thoughtful and methodologically rigorous letter. We particularly appreciate Dr. Russi’s continued engagement, who previously contributed an individual commentary on our work [1].
No takes yet. Share an insight, caveat, or question.
Bertolo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: